TITLE

Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients

AUTHOR(S)
Tigchelaar, I.; Gallandat, R.C.G.; Boonstra, P.W.; van Oeveren, W.
PUB. DATE
September 1998
SOURCE
Perfusion;1998, Vol. 13 Issue 5, p297
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Ten per cent low molecular weight hydroxyethyl starch is a plasma substitute only recently used as priming solution in an extracorporeal circuit, in contrast to human albumin and gelatin. To evaluate the effect of priming solutions on haemodynamics and colloid osmotic pressure, we studied 36 patients elected for cardiopulmonary bypass (CPB). They were randomly assigned to 2.5% hydroxyethyl starch, 3% gelatin or 4% human albumin priming solution. Total blood loss (perioperative + intensive care unit period) was higher in the gelatin group than in the albumin and hydroxyethyl starch groups. During CPB, the colloid osmotic pressure was best preserved in the gelatin group, although no excessively low colloid osmotic pressures were measured in the other two groups. Due to the extended half-life and the additional postoperative colloid administration, the hydroxyethyl starch group had a higher colloid osmotic pressure in the postoperative phase. We conclude that, next to human albumin, 2.5% hydroxyethyl starch is a safe CPB priming solution additive and is effective as plasma substitute. Its somewhat longer half-life requires adaptation of the routine protocol for transfusion of colloids and blood products.
ACCESSION #
4093525

 

Related Articles

  • A minimal priming technique that allows for a higher circulating hemoglobin on cardiopulmonary bypass. Cromer, M.J.; Wolk, D.R. // Perfusion;1998, Vol. 13 Issue 5, p311 

    Reduction in circuit prime during cardiopulmonary bypass has benefits for the patient with a low body surface area, anemia, patient refusal to receive blood products, and aids the practitioner's goal to minimize exposure to blood products. Described here is a simple, low-cost technique that has...

  • Selection of optimal quantity of hydroxyethyl starch in the cardiopulmonary bypass prime. Ali, Maha A.; Saleh, Mohamed // Perfusion;Jan2004, Vol. 19 Issue 1, p41 

    Ringer's solution prime reduces colloid osmotic pressure and causes edema during cardiopulmonary bypass, while hydroxyethyl starch (HES) can be used to attenuate this effect. Fifty patients were classified into five equal groups: Group I (preoperative patients) is the control group and the other...

  • A hyperosmolar-colloidal additive to the CPB-priming solution reduces fluid load and fluid extravasation during tepid CPB. Kvalheim, V.; Farstad, M.; Haugen, O.; Brekke, H.; Mongstad, A.; Nygreen, E.; Husby, P. // Perfusion;Jan2008, Vol. 23 Issue 1, p57 

    Cardiopulmonary bypass(CPB) is associated with fluid overload. We hypothesized that fluid gain during CPB could be reduced by substituting parts of a crystalloid prime with 7.2% hypertonic saline and 6% poly(O2-hydroxyethyl) starch solution (HyperHaes®). 14 animals were randomized to a...

  • The effects of tranexamic acid and 6% hydroxyethyl starch (HES) solution (130/0.4) on postoperative bleeding in coronary artery bypass graft (CABG) surgery. Yanartas, M.; Baysal, A.; Aydın, C.; Ay, Y.; Kara, İ.; Aydın, E.; Cevirme, D.; Köksal, C.; Sunar, H. // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 4, p5959 

    Background: The addition of 6% hydroxyethyl starch (HES) into Ringer lactate priming solution may have adverse effects on hemostasis in patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) with or without the use of tranexamic acid. Methods: In a...

  • Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery. Li, N.; Statkevicius, S.; Asgeirsson, B.; Schött, U. // Perioperative Medicine;9/29/2015, p1 

    Background: The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised...

  • Hydroxyethyl starch solutions should not be used in critically ill, sepsis, or burns patients, confirms EMA. Mayor, Susan // BMJ: British Medical Journal;10/19/2013, Vol. 347 Issue 7929, p4 

    The article reports on the European Medicines Agency's (EMA) Octobr 11, 2013 ruling that hydroxethyl starch solutions (HES) should not be used in critically ill patients or those with sepsis or burn injuries who require fluid replacement.

  • Modified ultrafiltration in paediatric cardiopulmonary bypass. Wang, W.; Huang, H.M.; Zhu, D.M.; Chen, H.; Su, Z.K.; Ding, W.X. // Perfusion;1998, Vol. 13 Issue 5, p304 

    Cardiopulmonary bypass (CPB), a nonphysiological procedure, is associated with haemodilution and the inflammatory response, causing the accumulation of body water and organ dysfunction. The purpose of this study was to evaluate the efficacy of modified ultrafiltration. Forty paediatric patients...

  • Miniaturization in cardiopulmonary bypass. von Segesser, Ludwig K.; Tozzi, Piergiorgio; Mallbiabrrena, Iker; Jegger, David; Horisberger, Judith; Corno, Antonio // Perfusion;Jul2003, Vol. 18 Issue 4, p145 

    Cardiopulmonary bypass (CPB) remains the key technology for more complex cardiac operations. The perfusion equipment used nowadays has seen tremendous progress since its introduction into clinical practice 50 years ago. However, overall, CPB is still far from perfect. Major haemodilution is not...

  • Effect of 6% Hydroxyethyl Starch 130/0.4 as a Priming Solution on Coagulation and Inflammation Following Complex Heart Surgery. Jang-Eun Cho; Jae-Kwang Shim; Jong-Won Song; Hye-Won Lee; Dong-Hwan Kim; Young-Lan Kwak // Yonsei Medical Journal;May2014, Vol. 55 Issue 3, p625 

    Purpose: Prolonged duration of cardiopulmonary bypass aggravates the degree of inflammation and coagulopathy. We investigated the influence of 6% hydroxyethyl starch (HES) 130/0.4 on coagulation and inflammation compared with albumin when used for both cardiopulmonary bypass priming and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics